Literature DB >> 28853438

Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.

Yu-Cheng Ho1, Tzer-Bin Lin2, Ming-Chun Hsieh1,3, Cheng-Yuan Lai1,4, Dylan Chou1,2, Yat-Pang Chau1, Gin-Den Chen5, Hsien-Yu Peng1.   

Abstract

The mechanisms underlying chronic stress-induced dysfunction of glutamatergic transmission that contribute to helplessness-associated depressive disorder are unknown. We investigated the relationship of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors and stress, and the neuroplastic changes of stress-induced depression-like behavior in the ventrolateral periaqueductal gray (vlPAG). We conducted whole-cell patch-clamp electrophysiological recordings in the vlPAG neurons. Depression-like behavior was assayed using tail suspension test and sucrose preference test. Surface and cytosolic glutamate receptor 1 (GluR1) AMPA receptor expression was analyzed using western blotting. Phosphorylated GluR1 expression was quantified using western blotting and immunohistochemical analysis. Unpredictable inescapable foot shock stress caused reduction in glutamatergic transmission originating from both presynaptic and postsynaptic loci in the vlPAG that was associated with behavioral despair and anhedonia in chronic stress-induced depression. Pharmacological inhibition of GluR1 function in the vlPAG caused depression-like behavior. Diminished glutamatergic transmission was due to reduced glutamate release presynaptically and enhanced GluR1-endocytosis from the cell surface postsynaptically. Chronic stress-induced neuroplastic changes and maladaptive behavior were reversed and mimicked by administration of glucocorticoid receptor (GR) antagonist and agonist, respectively. However, chronic stress did not affect γ-aminobutyric acid (GABA)-mediated inhibitory synaptic transmission in the vlPAG. These results demonstrate that depression-like behavior is associated with remarkable reduction in glutamatergic, but not GABAergic, transmission in the vlPAG. These neuroplastic changes and maladaptive behavior are attributed to GR-dependent mechanisms. As reduced GluR1-associated responses in the vlPAG contribute to chronic stress-induced neuroplastic changes, this cellular mechanism may be a critical component in the pathogenesis of stress-associated neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28853438      PMCID: PMC5729570          DOI: 10.1038/npp.2017.199

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  50 in total

1.  Phosphorylation of the AMPA receptor GluR1 subunit is required for synaptic plasticity and retention of spatial memory.

Authors:  Hey-Kyoung Lee; Kogo Takamiya; Jung-Soo Han; Hengye Man; Chong-Hyun Kim; Gavin Rumbaugh; Sandy Yu; Lin Ding; Chun He; Ronald S Petralia; Robert J Wenthold; Michela Gallagher; Richard L Huganir
Journal:  Cell       Date:  2003-03-07       Impact factor: 41.582

Review 2.  Diagnosis and definition of treatment-resistant depression.

Authors:  Maurizio Fava
Journal:  Biol Psychiatry       Date:  2003-04-15       Impact factor: 13.382

3.  GABAergic control of depression-related brain states.

Authors:  Bernhard Luscher; Thomas Fuchs
Journal:  Adv Pharmacol       Date:  2015-01-14

4.  Raphe AMPA receptors and nicotinic acetylcholine receptors mediate ketamine-induced serotonin release in the rat prefrontal cortex.

Authors:  Naoya Nishitani; Kazuki Nagayasu; Nozomi Asaoka; Mayumi Yamashiro; Hisashi Shirakawa; Takayuki Nakagawa; Shuji Kaneko
Journal:  Int J Neuropsychopharmacol       Date:  2014-05-23       Impact factor: 5.176

5.  gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitary-adrenal axis hyperactivity and antidepressant drug sensitivity reminiscent of melancholic forms of depression.

Authors:  Qiuying Shen; Rachnanjali Lal; Beth A Luellen; John C Earnheart; Anne Milasincic Andrews; Bernhard Luscher
Journal:  Biol Psychiatry       Date:  2010-07-01       Impact factor: 13.382

6.  Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.

Authors:  Zhen Ren; Horia Pribiag; Sarah J Jefferson; Matthew Shorey; Thomas Fuchs; David Stellwagen; Bernhard Luscher
Journal:  Biol Psychiatry       Date:  2016-02-13       Impact factor: 13.382

7.  Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants.

Authors:  Ronald S Duman; George K Aghajanian; Gerard Sanacora; John H Krystal
Journal:  Nat Med       Date:  2016-03       Impact factor: 53.440

8.  GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects.

Authors:  Jeffrey Burgdorf; Xiao-lei Zhang; Katherine L Nicholson; Robert L Balster; J David Leander; Patric K Stanton; Amanda L Gross; Roger A Kroes; Joseph R Moskal
Journal:  Neuropsychopharmacology       Date:  2012-12-05       Impact factor: 7.853

9.  Ionotropic glutamate-receptor antagonists inhibit the aversive effects of nitric oxide donor injected into the dorsolateral periaqueductal gray of rats.

Authors:  Fabrício Araújo Moreira; Moriana Ludmilla Molchanov; Francisco Silveira Guimarães
Journal:  Psychopharmacology (Berl)       Date:  2003-08-30       Impact factor: 4.530

10.  Decreased SGK1 Expression and Function Contributes to Behavioral Deficits Induced by Traumatic Stress.

Authors:  Pawel Licznerski; Vanja Duric; Mounira Banasr; Kambiz N Alavian; Kristie T Ota; Hyo Jung Kang; Elizabeth A Jonas; Robert Ursano; John H Krystal; Ronald S Duman
Journal:  PLoS Biol       Date:  2015-10-27       Impact factor: 8.029

View more
  12 in total

1.  (2R,6R)-hydroxynorketamine rapidly potentiates hippocampal glutamatergic transmission through a synapse-specific presynaptic mechanism.

Authors:  Lace M Riggs; Yasco Aracava; Panos Zanos; Jonathan Fischell; Edson X Albuquerque; Edna F R Pereira; Scott M Thompson; Todd D Gould
Journal:  Neuropsychopharmacology       Date:  2019-06-19       Impact factor: 7.853

2.  Rapid antidepressant-like effects of muscarinic receptor antagonists require BDNF-dependent signaling in the ventrolateral periaqueductal gray.

Authors:  Hung-Wei Kan; Wei-Hao Peng; Cheng-Chun Wu; Deng-Wu Wang; Ming Tatt Lee; Yung-Kuo Lee; Tian-Huei Chu; Yu-Cheng Ho
Journal:  Psychopharmacology (Berl)       Date:  2022-10-12       Impact factor: 4.415

Review 3.  The Periaqueductal Gray and Its Extended Participation in Drug Addiction Phenomena.

Authors:  Priscila Vázquez-León; Abraham Miranda-Páez; Jesús Chávez-Reyes; Gonzalo Allende; Paulino Barragán-Iglesias; Bruno A Marichal-Cancino
Journal:  Neurosci Bull       Date:  2021-07-24       Impact factor: 5.271

4.  Sex differences in innate and adaptive neural oscillatory patterns link resilience and susceptibility to chronic stress in rats.

Authors:  Rachel-Karson Thériault; Joshua D Manduca; Melissa L Perreault
Journal:  J Psychiatry Neurosci       Date:  2021-03-26       Impact factor: 6.186

5.  Sex Differences of Periaqueductal Grey Matter Functional Connectivity in Migraine.

Authors:  Kinga Gecse; Daniel Baksa; Dóra Dobos; Csaba Sandor Aranyi; Attila Galambos; Natália Kocsel; Edina Szabó; Gyöngyi Kökönyei; Miklós Emri; Gyorgy Bagdy; Gabriella Juhasz
Journal:  Front Pain Res (Lausanne)       Date:  2021-11-30

6.  The interrelationship of chronic cough and depression: a prospective population-based study.

Authors:  Johnmary T Arinze; Amy Hofman; Emmely W de Roos; Maria A J de Ridder; Katia M C Verhamme; Bruno Stricker; Guy G Brusselle; Annemarie I Luik
Journal:  ERJ Open Res       Date:  2022-04-04

7.  The Ventrolateral Periaqueductal Gray Contributes to Depressive-Like Behaviors in Recovery of Inflammatory Bowel Disease Rat Model.

Authors:  Chih-Yuan Ko; Ya-Bi Yang; Dylan Chou; Jian-Hua Xu
Journal:  Front Neurosci       Date:  2020-03-24       Impact factor: 4.677

8.  Activation of ventrolateral orbital cortex improves mouse neuropathic pain-induced anxiodepression.

Authors:  Hai-Yan Sheng; Su-Su Lv; Ya-Qi Cai; Wu Shi; Wei Lin; Ting-Ting Liu; Ning Lv; Hong Cao; Ling Zhang; Yu-Qiu Zhang
Journal:  JCI Insight       Date:  2020-10-02

9.  Effects of inflammatory pain on CB1 receptor in the midbrain periaqueductal gray.

Authors:  Adrianne R Wilson-Poe; Beth Wiese; Cherkaouia Kibaly; Lindsay Lueptow; Jeniffer Garcia; Preeti Anand; Catherine Cahill; Jose A Morón
Journal:  Pain Rep       Date:  2021-03-05

10.  The central nervous system can directly regulate breast cancer progression and blockage by quercetin.

Authors:  Tianyu Luo; Yanmei Zhang; Xiaoyuan Liu; Qianyi Liang; Ling Zhu; Hai Lu; Huachao Li; Hongyan Zhang; Chunmin Yang; Jiahua Wu; Rui Xu; Yuzhu Zhang; Qianjun Chen
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.